LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 2.49 | 771.67 | 985 | 867 | 1.1351 | 3.2281 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 2.49 | 771.67 | 987 | 867 | 1.1374 | 3.2791 | MN20160304_L01 | K06 |
| MCF 10A-H2B-mCherry | Alpelisib | 1 | 2.49 | 771.67 | 989 | 867 | 1.1397 | 3.3305 | MN20160304_L01 | J17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 2.49 | 771.67 | 990 | 867 | 1.1409 | 3.3565 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 2.49 | 771.67 | 992 | 867 | 1.1432 | 3.4087 | MN20160304_L01 | I04 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 3.21 | 770.25 | 1087 | 904 | 1.2016 | 3.4140 | MN20160304_L02 | J18 |
| MCF 10A-H2B-mCherry | Etoposide | 0.1 | 2.49 | 771.67 | 998 | 867 | 1.1501 | 3.5686 | MN20160304_L01 | J10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.31623 | 2.49 | 771.67 | 998 | 867 | 1.1501 | 3.5686 | MN20160304_L01 | J21 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.49 | 771.67 | 1008 | 867 | 1.1616 | 3.8457 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 2.49 | 771.67 | 1016 | 867 | 1.1708 | 4.0773 | MN20160304_L01 | K15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 2.49 | 771.67 | 1018 | 867 | 1.1731 | 4.1367 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 2.49 | 771.67 | 1019 | 867 | 1.1743 | 4.1665 | MN20160304_L01 | N07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 2.49 | 771.67 | 1021 | 867 | 1.1766 | 4.2267 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.21 | 770.25 | 1157 | 904 | 1.2790 | 4.7765 | MN20160304_L02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 2.49 | 771.67 | 1046 | 867 | 1.2054 | 5.0296 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 2.49 | 771.67 | 1052 | 867 | 1.2123 | 5.2367 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 2.49 | 771.67 | 1056 | 867 | 1.2169 | 5.3781 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 2.49 | 771.67 | 1060 | 867 | 1.2215 | 5.5222 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.31623 | 2.49 | 771.67 | 1076 | 867 | 1.2400 | 6.1256 | MN20160304_L01 | K08 |
| MCF 10A-H2B-mCherry | Alpelisib | 5.6234 | 2.49 | 771.67 | 1092 | 867 | 1.2584 | 6.7748 | MN20160304_L01 | J14 |